Studies have shown that in the development course of AD, the abnormal Aβ and tau proteins begin at the early stage of AD onset, while the abnormal glucose uptake and utilization mainly occur in the middle and later stages of the disease.48 This evidence concerns the gene MAPT and Alzheimer disease.